$0.09
(Market cap
$7 Mln
Revenue (TTM)
$4 Mln
P/E Ratio
--
P/B Ratio
2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.9 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-5.4
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
3,090,269
10 Years Aggregate
CFO
$-21.12 Mln
EBITDA
$-24.12 Mln
Net Profit
$-27.29 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Biomerica (BMRA)
| -8.3 | 51.0 | 9.5 | -18.9 | -39.3 | -42.8 | -20.3 |
|
BSE Sensex
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Biomerica (BMRA)
| 5.0 | -75.7 | -62.7 | -13.9 | -21.9 | 64.7 | 77.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Biomerica (BMRA)
|
2.3 | 6.6 | 4.3 | -4.2 | -96.0 | -98.5 | -- | 2.0 |
| 0.3 | 32.7 | 402.0 | -49.2 | -3.6 | -80.1 | -- | 0.8 | |
| 15.0 | 655.1 | 320.2 | -36.7 | -11.2 | -20.8 | -- | 3.8 | |
| 27.9 | 234.3 | 73.8 | 11.3 | 19.3 | 23.3 | 21.5 | 4.4 | |
| 103.4 | 4,679.4 | 1,352.0 | 96.3 | 11.2 | 11 | 49.7 | 5.5 | |
| 127.1 | 722.4 | 249.7 | 4.8 | 7.1 | 2.6 | 151.9 | 3.8 | |
| 3.6 | 28.2 | 0.0 | -28.0 | -- | -336.7 | -- | 2.8 | |
| 11.7 | 2,543.1 | 870.4 | -7.9 | 5.8 | -0.4 | -- | 1.2 | |
| 0.7 | 25.8 | 1.2 | -9.8 | -747.0 | -413 | -- | 19.1 | |
| 18.4 | 371.9 | 82.1 | 8.1 | 13.2 | 6.1 | 46 | 2.7 |
Shareholding Pattern
View DetailsAbout Biomerica (BMRA)
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's... diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. The company has strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs for launching the inFoods platform in Canada. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California. Read more
-
Chief Executive Officer
Mr. Zackary S. Irani
-
Chief Executive Officer
Mr. Zackary S. Irani
-
Headquarters
Irvine, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Biomerica (BMRA)
What is the current share price of Biomerica Inc (BMRA) Today?
The share price of Biomerica Inc (BMRA) is $2.31 (NASDAQ) as of 04-Sep-2026 13:33 EDT. Biomerica Inc (BMRA) has given a return of -39.28% in the last 3 years.
What is the current PB & PE ratio of Biomerica Inc (BMRA)?
Since, TTM earnings of Biomerica Inc (BMRA) is negative, P/E ratio is not available.
The P/B ratio of Biomerica Inc (BMRA) is 1.96 times as on 28-Aug-2026, a 48 discount to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-- |
-- |
2024 |
-- |
-- |
2023 |
-- |
-- |
2022 |
-- |
-- |
2021 |
-- |
-- |
What is the 52 Week High and Low of Biomerica Inc (BMRA)?
The 52-week high and low of Biomerica Inc (BMRA) are Rs 3.21 and Rs 1.45 as of 05-Sep-2026.
What is the market cap of Biomerica Inc (BMRA)?
Biomerica Inc (BMRA) has a market capitalisation of $ 7 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Biomerica Inc (BMRA)?
Before investing in Biomerica Inc (BMRA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.